T0007
Tacrolimus, CMIA
Test Details: Tacrolimus Chemiluminiscent microparticleimmunoassay (CMIA) is a delayed one-step immunoassay for the quantitative determination of tacrolimus in human whole blood using CMIA technology. The narrow therapeutic range of tacrolimus requires therapeutic drug monitoring to prevent transplant rejection and to minimize nephrotoxicity.
Category
Pre-test Information
Please indicate history of the drug dose taken, time of sample collection (Peak or Trough level) and clinical history along with the sample.
Report Delivery
1 working day
Gender
All
Organ
Kidney
Tacrolimus, CMIA
3600
Most Searched Diagnostic Tests